Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
human growth hormone
Biotech
Crinetics pads case for oral hormone disorder drug
Crinetics' oral med regulated levels of a hormone associated with acromegaly in a phase 3 test, setting up a regulatory submission in the second half.
Annalee Armstrong
Mar 19, 2024 9:30am
Crinetics growth disorder drug sees ph. 2 carcinoid syndrome win
Mar 13, 2024 9:16am
I-Mab sheds China footprint to transform into US-based biotech
Feb 7, 2024 8:50am
Lumos stock rockets on oral growth hormone phase 2 results
Nov 8, 2023 9:40am
Genexine's weekly growth hormone equal to Novo shot in phase 3
Aug 31, 2023 6:00am
Ascendis scores in phase 3 trial, a boost to endocrine portfolio
Mar 14, 2022 11:15am
